BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6316044)

  • 1. [Glucagonoma syndrome with a normal blood glucose curve].
    González de Zárate Apiñariz P; Alonso Alonso J; Vázquez García JA; Hernández Calvo J; Burgos Bretones J; Aguirre Errasti C; Díaz Pérez JL
    Med Clin (Barc); 1983 Oct; 81(9):396-8. PubMed ID: 6316044
    [No Abstract]   [Full Text] [Related]  

  • 2. [Glucagonoma syndrome with normal blood glucagon ].
    Quencez E; Zultak M; Blanc D; Gillet M; Laurent R
    Ann Dermatol Venereol; 1987; 114(9):1103-8. PubMed ID: 2829690
    [No Abstract]   [Full Text] [Related]  

  • 3. [A case of glucagonoma].
    Numakawa T; Ikeuchi T; Sugimasa T; Inoue S; Takamura Y; Suda T
    Nihon Naika Gakkai Zasshi; 1982 Jul; 71(7):977-84. PubMed ID: 6294199
    [No Abstract]   [Full Text] [Related]  

  • 4. [Glucagonoma and somatostatinoma].
    Yoshida H; Shimizu N
    Nihon Rinsho; 1982 Feb; 40(2):441-5. PubMed ID: 6283209
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of somatostatin and somatostatin analogs in a patient with a glucagonoma.
    Kahn CR; Bhathena SJ; Recant L; Rivier J
    J Clin Endocrinol Metab; 1981 Sep; 53(3):543-9. PubMed ID: 6114963
    [No Abstract]   [Full Text] [Related]  

  • 6. A glucagonoma syndrome.
    Mallinson CN; Bloom SR; Warin AP; Salmon PR; Cox B
    Lancet; 1974 Jul; 2(7871):1-5. PubMed ID: 4134714
    [No Abstract]   [Full Text] [Related]  

  • 7. Somatostatin analogue in treatment of coexisting glucagonoma and pancreatic pseudocyst: dissociation of responses.
    Moattari AR; Cho K; Vinik AI
    Surgery; 1990 Sep; 108(3):581-7. PubMed ID: 2168587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pancreatic function tests].
    Abe M; Ikeda Y; Yaginuma M; Shimizu N
    Nihon Rinsho; 1969 Feb; 27(2):291-300. PubMed ID: 4306418
    [No Abstract]   [Full Text] [Related]  

  • 9. Secretory response and immunochemical heterogeneity of glucagon in plasma and tumor extracts of a patient with glucagonoma.
    Torre L; Vazquez JA; Blázquez E
    Horm Res; 1986; 23(3):159-66. PubMed ID: 3005153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucagonoma syndrome.
    Hashizume T; Kiryu H; Noda K; Kano T; Nakano R
    J Am Acad Dermatol; 1988 Aug; 19(2 Pt 2):377-83. PubMed ID: 2842381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical correction of islet cell adenocarcinoma in a dog.
    Wilson JW; Hulse DA
    J Am Vet Med Assoc; 1974 Mar; 164(6):603-6. PubMed ID: 4360735
    [No Abstract]   [Full Text] [Related]  

  • 12. Recurrent pheochromocytoma associated with glucagonoma. A case report.
    Yao H; Fukiyama K; Kawano Y; Mizumoto K; Toyoshima S; Omae T
    Endocrinol Jpn; 1983 Apr; 30(2):163-6. PubMed ID: 6139277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose intolerance in a patient with insulinoma. Report of a case.
    Christiansen J; Munkgaard S
    Acta Chir Scand; 1974; 140(7):578-80. PubMed ID: 4376322
    [No Abstract]   [Full Text] [Related]  

  • 14. [Glucagonoma syndrome].
    Picard C; Mazer JM; Bilet S; Villette B; Penchet A; Toublanc M; Grossin M; Debussche X; Assan R; Belaïch S
    Ann Dermatol Venereol; 1988; 115(11):1142-5. PubMed ID: 2853600
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunoreactive insulin assay in insulinoma.
    Zeng XJ; Yao CZ; Zhong SX; Zhang JX; Zhu Y; Wu CY
    Chin Med J (Engl); 1983 Aug; 96(8):575-82. PubMed ID: 6315315
    [No Abstract]   [Full Text] [Related]  

  • 16. The metabolic effects of chronic hyperglucagonaemia.
    Nankervis A; Proietto J; Ng KW; Alford FP; Larkins R
    Clin Endocrinol (Oxf); 1981 Oct; 15(4):325-33. PubMed ID: 6274544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypoglycemia].
    Taskinen MR
    Duodecim; 1974; 90(5):320-34. PubMed ID: 4368154
    [No Abstract]   [Full Text] [Related]  

  • 18. [Glucagonoma syndrome. Unusual histologic image].
    Poiares Baptista A; Tellechea O; Aguiar M; Leitão A
    Ann Dermatol Venereol; 1987; 114(1):55-8. PubMed ID: 3034125
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of somatostatin on skin lesions and concentrations of plasma amino acids in a patient with glucagonoma-syndrome.
    Schmid R; Allescher HD; Schepp W; Hölscher A; Siewert R; Schusdziarra V; Classen M
    Hepatogastroenterology; 1988 Feb; 35(1):34-7. PubMed ID: 2896149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid assay of insulin in portosplenic blood for insulinoma.
    Yao CZ; Zeng XJ; Niu ZP
    Chin Med J (Engl); 1984 Jan; 97(1):57-60. PubMed ID: 6329612
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.